SOTAC

Sotac Pharmaceuticals Ltd Share Price

₹128.25 -6.75 (-5%)

26 Mar, 2025 16:20

SIP TrendupStart SIP in SOTAC

Start SIP

Performance

  • Low
  • ₹128
  • High
  • ₹129
  • 52 Week Low
  • ₹87
  • 52 Week High
  • ₹203
  • Open Price₹129
  • Previous Close₹135
  • Volume4,800

Investment Returns

  • Over 1 Month + 19.3%
  • Over 3 Month + 17.12%
  • Over 6 Month -10%
  • Over 1 Year + 2.6%
SIP Lightning

Smart Investing Starts Here Start SIP with Sotac Pharmaceuticals Ltd for Steady Growth!

Invest Now

Sotac Pharmaceuticals Ltd Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 142
  • P/B Ratio
  • 3
  • Average True Range
  • 5.4
  • EPS
  • 4.16
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.05
  • RSI
  • 70.3
  • MFI
  • 65.51

Sotac Pharmaceuticals Ltd Financials

Sotac Pharmaceuticals Ltd Technicals

EMA & SMA

Current Price
₹128.25
-6.75 (-5%)
pointer
  • stock-down_img
  • Bearish Moving Average 5
  • stock-up_img
  • Bullish Moving Average 11
  • 20 Day
  • ₹115.09
  • 50 Day
  • ₹115.65
  • 100 Day
  • ₹121.49
  • 200 Day
  • ₹125.03

Resistance and Support

135 Pivot Speed
  • R3 135.00
  • R2 135.00
  • R1 135.00
  • S1 135.00
  • S2 135.00
  • S3 135.00

What's your outlook on Sotac Pharmaceuticals Ltd?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sotac Pharmaceuticals Ltd has an operating revenue of Rs. 104.78 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 21% and 5% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 97 which is a GREAT score indicating consistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 56 indicates it belongs to a fair industry group of Medical-Biomed/Biotech and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sotac Pharmaceuticals Ltd Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-29 Quarterly Results
2024-08-13 Quarterly Results
2024-05-17 Audited Results & Others To consider other business matters
2023-11-06 Quarterly Results
2023-05-29 Audited Results

Sotac Pharmaceuticals Ltd F&O

Sotac Pharmaceuticals Ltd Shareholding Pattern

72.85%
8.88%
6.01%
12.26%

About Sotac Pharmaceuticals Ltd

  • NSE Symbol
  • SOTAC
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Sharadkumar Dashrathbhai Patel
  • ISIN
  • INE0O2D01012

Similar Stocks to Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Ltd FAQs

Sotac Pharmaceuticals Ltd share price is ₹128 As on 26 March, 2025 | 16:06

The Market Cap of Sotac Pharmaceuticals Ltd is ₹141.7 Cr As on 26 March, 2025 | 16:06

The P/E ratio of Sotac Pharmaceuticals Ltd is 39.6 As on 26 March, 2025 | 16:06

The PB ratio of Sotac Pharmaceuticals Ltd is 3 As on 26 March, 2025 | 16:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23